Open | $1.480 |
Close | $1.580 |
Volume / Avg. | 19.030K / 24.164K |
Day Range | 1.480 - 1.660 |
52 Wk Range | 1.190 - 2.400 |
Market Cap | $43.217M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 0.88% |
Days to Cover | 12.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dyadic International (NASDAQ: DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: NKGen Biotech (NASDAQ:NKGN), Estrella Immunopharma (NASDAQ:ESLA), Cellectar Biosciences (NASDAQ:CLRB), Bolt Biotherapeutics (NASDAQ:BOLT) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Dyadic International (NASDAQ: DYAI) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 6.00 expecting DYAI to rise to within 12 months (a possible 300.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dyadic International (NASDAQ: DYAI) is $1.5 last updated March 15, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Dyadic International.
Dyadic International’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.